Two of health secretary Robert F. Kennedy Jr.’s top lieutenants struck decidedly different tones at a forum held Tuesday by ...

With online health and wellness company Hims & Hers opening a new front in the GLP-1 compounding showdown Thursday, the ...

Richard Pazdur, a longtime regulator, said politics risks outweighing science at the agency.

Richard Pazdur had spent 26 years at the FDA before stepping down last year due to disagreements with Commissioner Marty Makary about lowering the number of clinical trials required for a new drug ...

The FDA has lifted longstanding and the most severe warnings off of hormone replacement therapies for menopausal women.

The Food and Drug Administration has approved removing safety warnings from several menopausal hormone therapy products. FDA ...

Novo Nordisk has also spoken out strongly against Hims & Hers' compounded Wegovy pill, with CEO Maziar Mike Doustdar telling ...

As commissioner of the U.S. Food and Drug Administration since March 2025, Dr. Marty Makary is responsible for greenlighting and regulating treatments, from drugs to vaccines. While some health ...

Echoing President Donald Trump’s call to accelerate medical innovation, Food and Drug Administration (FDA) Commissioner Marty Makary announced that the agency will no longer block companies from ...

While the first Trump administration required commonsense safety standards for the prescription of abortion drugs, the Biden administration removed almost all of them, including a requirement that ...